1. 137. OnabotulinumtoxinA prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union. (January 2015) Authors: Matharu, Manjit; Gomez, Julio Pascual; Remahl, Ingela Nilsson; Odom, Dawn; Gutierrez, Lia; Andrews, Elizabeth; Largent, Joan; Johannes, Catherine Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability. Issue 2 (1st February 2018) Authors: La, Elizabeth M.; Trantham, Laurel; Kurosky, Samantha K.; Odom, Dawn; Aris, Emmanuel; Hogea, Cosmina Journal: Human vaccines & immunotherapeutics Issue: Volume 14:Issue 2(2018) Page Start: 430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis. (3rd August 2017) Authors: Chirila, Costel; Mitra, Debanjali; Colosia, Ann; Ling, Caroline; Odom, Dawn; Iyer, Shrividya; Kaye, James A. Journal: Current medical research and opinion Issue: Volume 33:Number 8(2017) Page Start: 1457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial. (September 2021) Authors: Smith, Matthew R.; Shore, Neal; Tammela, Teuvo L.; Ulys, Albertas; Vjaters, Egils; Polyakov, Sergey; Jievaltas, Mindaugas; Luz, Murilo; Alekseev, Boris; Kuss, Iris; Le Berre, Marie-Aude; Mohamed, Ateesha F.; Odom, Dawn; Bartsch, Jennifer; Snapir, Amir; Sarapohja, Toni; Fizazi, Karim Journal: European journal of cancer Issue: Volume 154(2021) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Greater Efficacy with Secukinumab Treatment is Associated with Greater Psoriasis Symptom Relief: Results from Secukinumab Clinical Trial Data. Issue 2 (March 2017) Authors: Gottlieb, Alice B.; Strober, Bruce; Lebwohl, Mark; Kaufmann, Roland; Pariser, David; Narbutas, Redzinaldas; Nyirady, Judit; Zhao, Yang; Herrera, Vivian; McLeod, Lori; Odom, Dawn; Elewski, Boni E. Journal: Journal of psoriasis and psoriatic arthritis Issue: Volume 2:Issue 2(2017) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Longitudinal Modeling Approaches to Assess the Association Between Changes in 2 Clinical Outcome Assessments. (May 2018) Authors: Odom, Dawn; McLeod, Lori; Sherif, Bintu; Nelson, Lauren; McSorley, David Journal: Therapeutic innovation & regulatory science Issue: Volume 52:Number 3(2018:May) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Quality of life is maintained with ixazomib maintenance in post‐transplant newly diagnosed multiple myeloma: The TOURMALINE‐MM3 trial. (22nd February 2020) Authors: Schjesvold, Fredrik; Goldschmidt, Hartmut; Maisnar, Vladimir; Spicka, Ivan; Abildgaard, Neils; Rowlings, Philip; Cain, Lauren; Romanus, Dorothy; Suryanarayan, Kaveri; Rajkumar, Vincent; Odom, Dawn; Gnanasakthy, Ari; Dimopoulos, Meletios Journal: European journal of haematology Issue: Volume 104:Number 5(2020) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Real-world treatment utilization and safety of onabotulinumtoxinA for chronic migraine from an observational study in the European union. (25th December 2016) Authors: Matharu, Manjit; Pascual, Julio; Remahl, Ingela Nilsson; Straube, Andreas; Lum, Arlene; Davar, Gudarz; Odom, Dawn; Bennett, Lee; Proctor, Christina; Gutierrez, Lia; Andrews, Elizabeth; Johannes, Catherine Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Secukinumab Provides Clearer Skin and Better Control on Patient-Reported Psoriasis Symptoms of Itching, Pain, and Scaling than Placebo and Etanercept. Issue 4 (September 2016) Authors: Strober, Bruce; Sigurgeirsson, Bárður; Popp, Georg; Sinclair, Rodney; Krell, James; Stonkus, Sigitas; Septe, Marcis; Elewski, Boni E.; Gottlieb, Alice B.; Zhao, Yang; Herrera, Vivian; Mordin, Margaret; Odom, Dawn; Papavassilis, Charis; Nyirady, Judit; Lebwohl, Mark Journal: Journal of psoriasis and psoriatic arthritis Issue: Volume 1:Issue 4(2016) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe. (December 2017) Authors: Matharu, Manjit; Pascual, Julio; Nilsson Remahl, Ingela; Straube, Andreas; Lum, Arlene; Davar, Gudarz; Odom, Dawn; Bennett, Lee; Proctor, Christina; Gutierrez, Lia; Andrews, Elizabeth; Johannes, Catherine Journal: Cephalalgia Issue: Volume 37:Number 14(2017) Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗